Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Echo Therapeutics, Inc. (ECTE)

-NasdaqCM
3.10 Down 0.04(1.27%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012
Total Revenue 23   23   23   31  
Cost of Revenue -   -   -   -  
Gross Profit 23   23   23   31  
Operating Expenses
Research Development2,756  4,019  3,220  2,139  
Selling General and Administrative2,192  2,098  2,299  1,508  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (4,926) (6,095) (5,497) (3,617)
Income from Continuing Operations
Total Other Income/Expenses Net(69)2,996  1,682  (559)
Earnings Before Interest And Taxes(4,995)(3,099)(3,815)(4,176)
Interest Expense242  242  3,174  89  
Income Before Tax(5,237)(3,341)(6,988)(4,265)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(5,237)(3,341)(6,988)(4,265)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (5,237) (3,341) (6,988) (4,265)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (5,237) (3,341) (6,988) (4,265)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.